Overall metabolic syndrome prevalence in the HIV-infected: Adult Treatment Panel III (ATPIII) 2001 criteria.
Kim A. Nguyen
Nasheeta Peer
Edward J. Mills
Andre P. Kengne
10.1371/journal.pone.0150970.g002
https://plos.figshare.com/articles/figure/Overall_metabolic_syndrome_prevalence_in_the_HIV_infected_Adult_Treatment_Panel_III_ATPIII_2001_criteria_/3134863
<p>For each study the black box represents the study estimate (prevalence of metabolic syndrome [MS]) and the horizontal bar about the 95% confidence intervals (95%CI). The size of the boxes is proportional to the inverse variance. The diamond at the lower tail of the figure is for the pooled effect estimates from random effects models. The proportional contribution of each study (weight) to the pooled estimates is also shown, together with the prevalence estimates and measures of heterogeneity. The dotted vertical line is centred on the pooled estimates.</p>
2016-03-23 06:13:51
EGIR
ATPIII
JIS
NNRTI
Metabolic Syndrome Prevalence
age 41 years
MS prevalence
IDF
publication
criteria
CI
infection
participant
severity
HIV